However, significantly higher levels of serum TxB2 were detected in patients with serum albumin <3.5 g/dL compared with those having albumin ≥3.5 g/dL, suggesting impaired COX-1 inhibition in hypo-albuminemic T2DM aspirin-treated patients. This evidence concerns the gene ALB and type 2 diabetes mellitus.